TMUS vs ZVRA · P/E 19, rev $22.79B vs P/E 6.3, rev $75.9M
T-Mobile US Inc (TMUS) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
TMUS currently screens at market cap $196.21B and trailing P/E 19.3. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the TMUS and ZVRA stock pages for the full models.
Not investment advice.